Consumer perception, knowledge, and uses of cannabidiol

Introduction The legalization of cannabidiol (CBD) across the United States, in varying degrees, has made CBD easily accessible to consumers for complementary and medical purposes. However, there is a paucity of scientific evidence on the benefits and risks of commercially available CBD. In the lite...

Full description

Bibliographic Details
Published in:	Mental Health Clinician
Main Authors:	Nguyen Cambrey PharmD, Moeller Karen E. PharmD, McGuire Michael PharmD, Melton Brittany L. PharmD, PhD
Format:	Article
Language:	English
Published:	American Association of Psychiatric Pharmacists 2023-10-01
Subjects:	cannabidiol consumer perception drug resources survey
Online Access:	https://theijpt.org/doi/pdf/10.9740/mhc.2023.10.217

Similar Items

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns
by: Danielle Dauchot, PharmD, et al.
Published: (2024-02-01)

Implementation of mMINDS monitoring for alcohol withdrawal at an inpatient academic psychiatric facility
by: Leah A. Surbaugh, PharmD, BCPP, et al.
Published: (2025-08-01)

Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers
by: Carrillo Nina PharmD, et al.
Published: (2023-08-01)

Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022-06-01)

Developing personas to examine older adult engagement with televised direct-to-consumer advertisements: A theory based approach
by: Emily L. Hoffins, MS, et al.
Published: (2025-06-01)

Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients
by: Muzna Suhail MPhil, et al.
Published: (2024-04-01)

Evaluating Pennsylvania Pharmacists’ Provision of Community-based Patient Care Services to Develop a Statewide Practice Network
by: Maria A. Osborne, PharmD, et al.
Published: (2011-01-01)

Adverse childhood experiences among California student pharmacists
by: Shawn R. Smith, PharmD, APh, et al.
Published: (2024-02-01)

Unlocking the therapeutic capabilities of GPCR in the treatment of ischemic stroke: A translational literature
by: Girish B S, Pharm.D, et al.
Published: (2024-12-01)

Alternatives to Hydrocortisone for Hemodynamic Support in Septic Shock Management Due to Medication Shortage
by: Mohammed Aldhaeefi, PharmD, et al.
Published: (2023-07-01)

Clinical Characteristics and Outcomes of Deep Vein Thrombosis in Relation to Location: A Retrospective Analysis Study
by: Majed S. Al Yami PharmD, et al.
Published: (2025-01-01)

Evaluation of the Clinical Outcomes of Apixaban Use in Patients with Atrial Fibrillation and Uncontrolled Hypothyroidism: A Real-world Evidence
by: Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, et al.
Published: (2025-09-01)

Attitude and Perception of Physicians and Nurses Toward the Role of Clinical Pharmacists in Riyadh, Saudi Arabia: A Qualitative Study
by: Nada Alsuhebany BSPharm, PharmD, et al.
Published: (2019-11-01)

Evaluation of the tacrolimus drug interaction with voriconazole vs clotrimazole in heart transplant recipients
by: Elizabeth Posney, PharmD, et al.
Published: (2024-05-01)

Evaluating the Efficacy and Safety of Direct Oral Anticoagulants Compared to Vitamin K Antagonists in Patients with Antiphospholipid Syndrome: Updated Systematic Review and Meta-Analysis
by: Lama Alfehaid PharmD, MME, et al.
Published: (2025-08-01)

Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A decade-long retrospective analysis (2012-2021)
by: Joelle Dagher, PharmD, PhD, et al.
Published: (2024-02-01)

Survey of prescriptive authority among psychiatric pharmacists in the United States
by: Kelly C. Lee, PharmD, MAS, APh, BCPP, FCCP, et al.
Published: (2023-03-01)

Outcomes Associated with Time in Therapeutic Range for Patients Receiving Intravenous Unfractionated Heparin
by: Mujtaba Mahmud PharmD, et al.
Published: (2025-08-01)

Assessing intradisciplinary pharmacy communication related to transitions of care
by: Letitia N. Warunek, PharmD, BCPS, et al.
Published: (2024-06-01)

Don’t Leave Without Them: Dispensing asthma medications to pediatric patients upon discharge is associated with decreased hospital readmissions
by: Aleda M.H. Chen, Pharm.D.,M.S., Ph.D., et al.
Published: (2012-01-01)

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)

Pharmacologic management of adolescent catatonia: A dual-case series
by: Lauren Leiby, PharmD, BCPP, et al.
Published: (2024-06-01)

Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review
by: Laura M. Koppen PharmD, et al.
Published: (2017-10-01)

Retrospective Analysis of Medication Adherence and Cost Following Medication Therapy Management
by: Ashley Branham, PharmD, et al.
Published: (2010-01-01)

Anticonvulsant Effects of Aerial Parts of Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors
by: Amir Rashidian PharmD, PhD, et al.
Published: (2017-10-01)

Clinical Effects of Krachaidum (): A Systematic Review
by: Surasak Saokaew PharmD, PhD, et al.
Published: (2017-07-01)

Ultrasound-Assisted Catheter-Directed Thrombolysis for the Management of Pulmonary Embolism:
by: Jasmine Ventenilla PharmD, et al.
Published: (2024-02-01)

Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)

Over-the-Counter Medication Use, Perceived Safety, and Decision-Making Behaviors in Pregnant Women
by: Katie L. Kline, Pharm.D. Candidate 2011, et al.
Published: (2011-01-01)

Postpartum prophylaxis of venous thromboembolism with anticoagulation: A case report
by: Yahya A. Mohzari, Pharm.D, et al.
Published: (2021-04-01)

Quetiapine and olanzapine misuse prevalence in a US general population sample
by: Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS, et al.
Published: (2023-04-01)

The Role of Clinical Pharmacists in Modifying Cardiovascular Disease Risk Factors
by: DeeAnn Dugan, PharmD, BCAP, et al.
Published: (2013-01-01)

Comparison of Fixed Versus Weight-Based Prothrombin Complex Concentrate Dosing Strategies for Factor Xa Inhibitor Reversal
by: Snyder Brett PharmD, et al.
Published: (2024-05-01)

Abuse liability of gabapentin in the Saudi population after the pregabalin restriction: A cross-sectional study
by: Amina A. Alkhalaf, PharmD, et al.
Published: (2021-10-01)

Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients
by: Danial Chowdhury, PharmD, et al.
Published: (2024-04-01)

Evaluation of the use of chlorpromazine for agitation in pediatric patients
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)

Community Pharmacy-Based Blood Pressure Screening in Newfoundland and Labrador, Canada for World Hypertension Day 2022: A Cross-Sectional Study
by: Tiffany A. Lee, BSc(Pharm), PharmD, PhD(c), et al.
Published: (2024-05-01)

Patients’ Knowledge of and Practices Relating to the Disposal of Used Insulin Needles
by: Kerri T. Musselman, PharmD, et al.
Published: (2010-01-01)

The use of the ketogenic diet in the treatment of psychiatric disorders
by: Erika E. Tillery, PharmD, et al.
Published: (2021-05-01)

Increasing access to psychiatric care during the COVID-19 pandemic through mental health clinical pharmacy specialist services
by: Vickery P. Brittany PharmD, BCPS, BCPP, CPP, et al.
Published: (2023-08-01)